Beckman Coulter plans $4, high-volume COVID-19 antigen test

Beckman Coulter plans $4, high-volume COVID-19 antigen test

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March.

Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up to 25 million per month by March.

The Access antigen assay is designed for high-throughput laboratory hardware and can deliver individual results in 30 minutes while processing up to 200 samples per hour. The company said it is currently submitting the test to the FDA for emergency review.

Read the full article at: www.fiercebiotech.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *